A-358 Extended linearity studies for pO2, pCO2, K+ Cl- on GEM 5000 blood gas analyzers using a combination of verification materials

Abstract Background Blood gas analyzers (BGA) measure blood gases pO2,pCO2,O2Hb,COHb,MetHb, and several analytes in the workup and management of acid-base disorders. GEM 5000 BGA (Instrumentation Laboratory, a Werfen Company) have very broad reportable ranges for the measured analytes. However, manu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical chemistry (Baltimore, Md.) Md.), 2024-10, Vol.70 (Supplement_1)
Hauptverfasser: Samara Simha Subhash Chandra, V, Khatoon, H, Yeo, K J
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Supplement_1
container_start_page
container_title Clinical chemistry (Baltimore, Md.)
container_volume 70
creator Samara Simha Subhash Chandra, V
Khatoon, H
Yeo, K J
description Abstract Background Blood gas analyzers (BGA) measure blood gases pO2,pCO2,O2Hb,COHb,MetHb, and several analytes in the workup and management of acid-base disorders. GEM 5000 BGA (Instrumentation Laboratory, a Werfen Company) have very broad reportable ranges for the measured analytes. However, manufacturer’s current linearity materials do not cover the entire reportable ranges claims. This poses challenge to clinical laboratories, especially for pO2 and pCO2 to comply with College of American Pathologists (CAP) requirements to verify instruments performance every six months through the entire reportable range. We evaluated secondary materials in combination with manufacturer’s primary linearity materials for pO2, pCO2, K+ and Cl- for an extended linearity verification. Methods Routine linearity studies was performed with PVP (5-levels), a primary material provided by the GEM 5000 analyzer manufacturer. Hypoxic (pO2: 5-25mmHg) and hyperbaric (pO2: 600-670mmHg) materials obtained from Eurotrol Inc. and VK-R5 linearity material (Radiometer America Inc.) for pCO2, K+ and Cl- were processed on GEM 5000. All materials at all levels were assayed in duplicate. Results from PVP, Eurotrol and VK-R5 were combined from low to high levels to assess linearity verification. Results Linearity range of 15-630mmHg with r2=0.99 was verified for pO2. Using a combination of VK-R5 with PVP, a linearity range of 14-127 mmHg (r2=0.99) for pCO2, 1.1-14.1 mmol/L (r2=1.00) for K+, and 51-153 mmol/L (r2=1.00) for Cl-were verified. See table for details. Conclusions A combination of BGA manufacturer’s primary linearity material with secondary vendors material was useful in addressing linearity verification for blood gases pO2, pCO2, and electrolytes K+Cl- over an extended range close to the manufacturer’s claims. We recommend other laboratories that experience similar BGA linearity verification challenges to consider this approach for verification of the manufacturer’s claims. It would have been very helpful if manufacturer can provide materials that cover both the lower and upper limits of their claims.
doi_str_mv 10.1093/clinchem/hvae106.352
format Article
fullrecord <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_clinchem_hvae106_352</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/clinchem/hvae106.352</oup_id><sourcerecordid>10.1093/clinchem/hvae106.352</sourcerecordid><originalsourceid>FETCH-LOGICAL-c852-aaca7086728b432c27630908bb9f644e48afe8eab7e00fbf81a93b14205033533</originalsourceid><addsrcrecordid>eNqNkL1OwzAYRS0EEqXwBgzfDmnt2E6csYpKQRR16R7Zjt0a5aey04oy8-C4atlZ7tUdzh0OQo8ETwgu6FQ3rtNb0063B2kIziaUp1doRDjFieAZuUYjjHGRFITlt-guhM84WS6yEfqZJZQLmH8NpqtNDfHJSO-GI4RhXzsTwPYedqv0GXblKd-foGwS6DtYzD-AxyNQTd_XsJEBZCeb47fxAfbBdRuQoPtWuU4OLgK9hYPxzjp93q0c4pRNuEc3NpZ5uPQYrV_m6_I1Wa4Wb-VsmWjB00RKLXMssjwVitFUp3lGcYGFUoXNGDNMSGuEkSo3GFtlBZEFVYSlmGNKOaVjxM632vcheGOrnXet9MeK4OoksvoTWV1EVlFkxKZnrN_v_kf8Anf2eLw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A-358 Extended linearity studies for pO2, pCO2, K+ Cl- on GEM 5000 blood gas analyzers using a combination of verification materials</title><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Samara Simha Subhash Chandra, V ; Khatoon, H ; Yeo, K J</creator><creatorcontrib>Samara Simha Subhash Chandra, V ; Khatoon, H ; Yeo, K J</creatorcontrib><description>Abstract Background Blood gas analyzers (BGA) measure blood gases pO2,pCO2,O2Hb,COHb,MetHb, and several analytes in the workup and management of acid-base disorders. GEM 5000 BGA (Instrumentation Laboratory, a Werfen Company) have very broad reportable ranges for the measured analytes. However, manufacturer’s current linearity materials do not cover the entire reportable ranges claims. This poses challenge to clinical laboratories, especially for pO2 and pCO2 to comply with College of American Pathologists (CAP) requirements to verify instruments performance every six months through the entire reportable range. We evaluated secondary materials in combination with manufacturer’s primary linearity materials for pO2, pCO2, K+ and Cl- for an extended linearity verification. Methods Routine linearity studies was performed with PVP (5-levels), a primary material provided by the GEM 5000 analyzer manufacturer. Hypoxic (pO2: 5-25mmHg) and hyperbaric (pO2: 600-670mmHg) materials obtained from Eurotrol Inc. and VK-R5 linearity material (Radiometer America Inc.) for pCO2, K+ and Cl- were processed on GEM 5000. All materials at all levels were assayed in duplicate. Results from PVP, Eurotrol and VK-R5 were combined from low to high levels to assess linearity verification. Results Linearity range of 15-630mmHg with r2=0.99 was verified for pO2. Using a combination of VK-R5 with PVP, a linearity range of 14-127 mmHg (r2=0.99) for pCO2, 1.1-14.1 mmol/L (r2=1.00) for K+, and 51-153 mmol/L (r2=1.00) for Cl-were verified. See table for details. Conclusions A combination of BGA manufacturer’s primary linearity material with secondary vendors material was useful in addressing linearity verification for blood gases pO2, pCO2, and electrolytes K+Cl- over an extended range close to the manufacturer’s claims. We recommend other laboratories that experience similar BGA linearity verification challenges to consider this approach for verification of the manufacturer’s claims. It would have been very helpful if manufacturer can provide materials that cover both the lower and upper limits of their claims.</description><identifier>ISSN: 0009-9147</identifier><identifier>EISSN: 1530-8561</identifier><identifier>DOI: 10.1093/clinchem/hvae106.352</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><ispartof>Clinical chemistry (Baltimore, Md.), 2024-10, Vol.70 (Supplement_1)</ispartof><rights>Association for Diagnostics &amp; Laboratory Medicine 2024. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Samara Simha Subhash Chandra, V</creatorcontrib><creatorcontrib>Khatoon, H</creatorcontrib><creatorcontrib>Yeo, K J</creatorcontrib><title>A-358 Extended linearity studies for pO2, pCO2, K+ Cl- on GEM 5000 blood gas analyzers using a combination of verification materials</title><title>Clinical chemistry (Baltimore, Md.)</title><description>Abstract Background Blood gas analyzers (BGA) measure blood gases pO2,pCO2,O2Hb,COHb,MetHb, and several analytes in the workup and management of acid-base disorders. GEM 5000 BGA (Instrumentation Laboratory, a Werfen Company) have very broad reportable ranges for the measured analytes. However, manufacturer’s current linearity materials do not cover the entire reportable ranges claims. This poses challenge to clinical laboratories, especially for pO2 and pCO2 to comply with College of American Pathologists (CAP) requirements to verify instruments performance every six months through the entire reportable range. We evaluated secondary materials in combination with manufacturer’s primary linearity materials for pO2, pCO2, K+ and Cl- for an extended linearity verification. Methods Routine linearity studies was performed with PVP (5-levels), a primary material provided by the GEM 5000 analyzer manufacturer. Hypoxic (pO2: 5-25mmHg) and hyperbaric (pO2: 600-670mmHg) materials obtained from Eurotrol Inc. and VK-R5 linearity material (Radiometer America Inc.) for pCO2, K+ and Cl- were processed on GEM 5000. All materials at all levels were assayed in duplicate. Results from PVP, Eurotrol and VK-R5 were combined from low to high levels to assess linearity verification. Results Linearity range of 15-630mmHg with r2=0.99 was verified for pO2. Using a combination of VK-R5 with PVP, a linearity range of 14-127 mmHg (r2=0.99) for pCO2, 1.1-14.1 mmol/L (r2=1.00) for K+, and 51-153 mmol/L (r2=1.00) for Cl-were verified. See table for details. Conclusions A combination of BGA manufacturer’s primary linearity material with secondary vendors material was useful in addressing linearity verification for blood gases pO2, pCO2, and electrolytes K+Cl- over an extended range close to the manufacturer’s claims. We recommend other laboratories that experience similar BGA linearity verification challenges to consider this approach for verification of the manufacturer’s claims. It would have been very helpful if manufacturer can provide materials that cover both the lower and upper limits of their claims.</description><issn>0009-9147</issn><issn>1530-8561</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqNkL1OwzAYRS0EEqXwBgzfDmnt2E6csYpKQRR16R7Zjt0a5aey04oy8-C4atlZ7tUdzh0OQo8ETwgu6FQ3rtNb0063B2kIziaUp1doRDjFieAZuUYjjHGRFITlt-guhM84WS6yEfqZJZQLmH8NpqtNDfHJSO-GI4RhXzsTwPYedqv0GXblKd-foGwS6DtYzD-AxyNQTd_XsJEBZCeb47fxAfbBdRuQoPtWuU4OLgK9hYPxzjp93q0c4pRNuEc3NpZ5uPQYrV_m6_I1Wa4Wb-VsmWjB00RKLXMssjwVitFUp3lGcYGFUoXNGDNMSGuEkSo3GFtlBZEFVYSlmGNKOaVjxM632vcheGOrnXet9MeK4OoksvoTWV1EVlFkxKZnrN_v_kf8Anf2eLw</recordid><startdate>20241002</startdate><enddate>20241002</enddate><creator>Samara Simha Subhash Chandra, V</creator><creator>Khatoon, H</creator><creator>Yeo, K J</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20241002</creationdate><title>A-358 Extended linearity studies for pO2, pCO2, K+ Cl- on GEM 5000 blood gas analyzers using a combination of verification materials</title><author>Samara Simha Subhash Chandra, V ; Khatoon, H ; Yeo, K J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c852-aaca7086728b432c27630908bb9f644e48afe8eab7e00fbf81a93b14205033533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Samara Simha Subhash Chandra, V</creatorcontrib><creatorcontrib>Khatoon, H</creatorcontrib><creatorcontrib>Yeo, K J</creatorcontrib><collection>CrossRef</collection><jtitle>Clinical chemistry (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Samara Simha Subhash Chandra, V</au><au>Khatoon, H</au><au>Yeo, K J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A-358 Extended linearity studies for pO2, pCO2, K+ Cl- on GEM 5000 blood gas analyzers using a combination of verification materials</atitle><jtitle>Clinical chemistry (Baltimore, Md.)</jtitle><date>2024-10-02</date><risdate>2024</risdate><volume>70</volume><issue>Supplement_1</issue><issn>0009-9147</issn><eissn>1530-8561</eissn><abstract>Abstract Background Blood gas analyzers (BGA) measure blood gases pO2,pCO2,O2Hb,COHb,MetHb, and several analytes in the workup and management of acid-base disorders. GEM 5000 BGA (Instrumentation Laboratory, a Werfen Company) have very broad reportable ranges for the measured analytes. However, manufacturer’s current linearity materials do not cover the entire reportable ranges claims. This poses challenge to clinical laboratories, especially for pO2 and pCO2 to comply with College of American Pathologists (CAP) requirements to verify instruments performance every six months through the entire reportable range. We evaluated secondary materials in combination with manufacturer’s primary linearity materials for pO2, pCO2, K+ and Cl- for an extended linearity verification. Methods Routine linearity studies was performed with PVP (5-levels), a primary material provided by the GEM 5000 analyzer manufacturer. Hypoxic (pO2: 5-25mmHg) and hyperbaric (pO2: 600-670mmHg) materials obtained from Eurotrol Inc. and VK-R5 linearity material (Radiometer America Inc.) for pCO2, K+ and Cl- were processed on GEM 5000. All materials at all levels were assayed in duplicate. Results from PVP, Eurotrol and VK-R5 were combined from low to high levels to assess linearity verification. Results Linearity range of 15-630mmHg with r2=0.99 was verified for pO2. Using a combination of VK-R5 with PVP, a linearity range of 14-127 mmHg (r2=0.99) for pCO2, 1.1-14.1 mmol/L (r2=1.00) for K+, and 51-153 mmol/L (r2=1.00) for Cl-were verified. See table for details. Conclusions A combination of BGA manufacturer’s primary linearity material with secondary vendors material was useful in addressing linearity verification for blood gases pO2, pCO2, and electrolytes K+Cl- over an extended range close to the manufacturer’s claims. We recommend other laboratories that experience similar BGA linearity verification challenges to consider this approach for verification of the manufacturer’s claims. It would have been very helpful if manufacturer can provide materials that cover both the lower and upper limits of their claims.</abstract><cop>US</cop><pub>Oxford University Press</pub><doi>10.1093/clinchem/hvae106.352</doi></addata></record>
fulltext fulltext
identifier ISSN: 0009-9147
ispartof Clinical chemistry (Baltimore, Md.), 2024-10, Vol.70 (Supplement_1)
issn 0009-9147
1530-8561
language eng
recordid cdi_crossref_primary_10_1093_clinchem_hvae106_352
source Oxford University Press Journals All Titles (1996-Current)
title A-358 Extended linearity studies for pO2, pCO2, K+ Cl- on GEM 5000 blood gas analyzers using a combination of verification materials
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T01%3A29%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A-358%20Extended%20linearity%20studies%20for%20pO2,%20pCO2,%20K+%20Cl-%20on%20GEM%205000%20blood%20gas%20analyzers%20using%20a%20combination%20of%20verification%20materials&rft.jtitle=Clinical%20chemistry%20(Baltimore,%20Md.)&rft.au=Samara%20Simha%20Subhash%20Chandra,%20V&rft.date=2024-10-02&rft.volume=70&rft.issue=Supplement_1&rft.issn=0009-9147&rft.eissn=1530-8561&rft_id=info:doi/10.1093/clinchem/hvae106.352&rft_dat=%3Coup_cross%3E10.1093/clinchem/hvae106.352%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/clinchem/hvae106.352&rfr_iscdi=true